Complement activation after oxidative stress -: Role of the lectin complement pathway

被引:286
作者
Collard, CD
Väkevä, A
Morrissey, MA
Agah, A
Rollins, SA
Reenstra, WR
Buras, JA
Meri, S
Stahl, GL
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med,Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Pain & Perioperat Med, Boston, MA 02115 USA
[2] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Helsinki, Finland
[4] Alex Pharmaceut, New Haven, CT USA
[5] Boston Univ, Sch Med, Dept Clin Pathol, Boston, MA 02118 USA
[6] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Emergency Med, Boston, MA USA
关键词
D O I
10.1016/S0002-9440(10)65026-2
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The complement system plays an important role in mediating tissue injury after oxidative stress. The role of mannose-binding lectin (MBL) and the lectin complement pathway (LCP) in mediating complement activation after endothelial oxidative stress was investigated, iC3b deposition on hypoxic (24 hours; 1% O-2)/ reoxygenated (3 hours; 21% O-2) human endothelial cells was attenuated by N-acetyl-D-glucosamine or D-mannose, but not L-mannose, in a dose-dependent manner. Endothelial iC3b deposition after oxidative stress was also attenuated in MBL-deficient serum. Novel, functionally inhibitory, anti-human MBL mono-clonal antibodies attenuated MBL-dependent C3 deposition on mannan-coated plates in a dose-dependent manner. Treatment of human serum with anti-MBL monoclonal antibodies inhibited MBL and C3 deposition after endothelial oxidative stress. Consistent with our in vitro findings, C3 and MBL immunostaining throughout the ischemic area at risk increased during rat myocardial reperfusion in vivo. These data suggest that the LCP mediates complement activation after tissue oxidative stress. Inhibition of MBL may represent a novel therapeutic strategy for ischemia/reperfusion injury and other complement-mediated disease states.
引用
收藏
页码:1549 / 1556
页数:8
相关论文
共 34 条
  • [1] LIMITATION OF REPERFUSION INJURY BY A MONOCLONAL-ANTIBODY TO C5A DURING MYOCARDIAL-INFARCTION IN PIGS
    AMSTERDAM, EA
    STAHL, GL
    PAN, HL
    RENDIG, SV
    FLETCHER, MP
    LONGHURST, JC
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 268 (01): : H448 - H457
  • [2] Buerke M, 1998, J PHARMACOL EXP THER, V286, P429
  • [3] CARDIOPROTECTIVE EFFECTS OF A C1 ESTERASE INHIBITOR IN MYOCARDIAL-ISCHEMIA AND REPERFUSION
    BUERKE, M
    MUROHARA, T
    LEFER, AM
    [J]. CIRCULATION, 1995, 91 (02) : 393 - 402
  • [4] Endothelial nuclear factor-κB translocation and vascular cell adhesion molecule-1 induction by complement inhibition with anti-human C5 therapy or cGMP analogues
    Collard, CD
    Agah, A
    Reenstra, W
    Buras, J
    Stahl, GL
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (11) : 2623 - 2629
  • [5] Hypoxia-induced expression of complement receptor type 1 (CR1, CD35) in human vascular endothelial cells
    Collard, CD
    Bukusoglu, C
    Agah, A
    Colgan, SP
    Reenstra, WR
    Morgan, BP
    Stahl, GL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1999, 276 (02): : C450 - C458
  • [6] Collard CD, 1997, CIRCULATION, V96, P326
  • [7] Complement activation following reoxygenation of hypoxic human endothelial cells:: Role of intracellular reactive oxygen species, NF-κB and new protein synthesis
    Collard, CD
    Agah, A
    Stahl, GL
    [J]. IMMUNOPHARMACOLOGY, 1998, 39 (01): : 39 - 50
  • [8] IMPROVED MOUNTANT FOR IMMUNOFLUORESCENCE PREPARATIONS
    HEIMER, GV
    TAYLOR, CED
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1974, 27 (03) : 254 - 256
  • [9] PHLOGISTIC ROLE OF C3 LEUKOTACTIC FRAGMENTS IN MYOCARDIAL INFARCTS OF RATS
    HILL, JH
    WARD, PA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1971, 133 (04) : 885 - &
  • [10] IKEDA K, 1987, J BIOL CHEM, V262, P7451